Ernexa Therapeutics Inc. Debt Instrument, Face Amount
Ernexa Therapeutics Inc. (ERNA) had Debt Instrument, Face Amount of $2.03 million as of 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2021-03-11
- 2020-12-31: Debt Instrument, Face Amount $2.03M.
- 2020-09-30: Debt Instrument, Face Amount $3.35M.
- 2020-06-30: Debt Instrument, Face Amount $3.25M.
- 2017-09-30: Debt Instrument, Face Amount $804.00K.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2020-12-31 | $2.03M 10-K · filed 2021-03-11 |
| 2020-09-30 | $3.35M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $3.25M 10-Q · filed 2020-08-07 |
| 2017-09-30 | $804.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.01M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $1.30M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $1.61M 10-K · filed 2017-03-09 |
| 2016-09-30 | $1.49M 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |